GemPharmatech Co., Ltd. (SHA:688046)
China flag China · Delayed Price · Currency is CNY
31.39
-3.11 (-9.01%)
Nov 16, 2026, 4:00 PM EST

GemPharmatech Revenue

GemPharmatech had revenue of 264.44M CNY in the quarter ending September 30, 2026, with 31.71% growth. This brings the company's total for the last twelve months to 941.80M, up 25.12% year-over-year. In the year 2025, GemPharmatech had annual revenue of 793.39M with 15.51% growth. That makes GemPharmatech the 20,104th largest company in the world by revenue and 3,693rd in China.

Revenue (ttm)
941.80M
Revenue Growth
+25.12%
P/S Ratio
13.64
Revenue / Employee
592.33K
Employees
1,692
Market Cap
12.84B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Commercial Mouse Model Sales 438.77M 55.3%
  • Functional Efficacy Business 200.19M 25.2%
  • Custom Breeding Business 83.99M 10.6%
  • Model Creation Business 47.48M 6.0%
  • Agent Import and Export and Others 22.24M 2.8%
  • Unallocated Other Operations 723.07K 0.1%

By Geography

Chart
  • China 640.78M 80.8%
  • Overseas 151.88M 19.2%
Fiscal year ended Dec 31, 2025 See the full GemPharmatech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025793.39M106.55M15.51%
Dec 31, 2024686.84M64.65M10.39%
Dec 31, 2023622.19M105.64M20.45%
Dec 31, 2022516.55M122.76M31.17%
Dec 31, 2021393.79M131.87M50.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.